(Q51611436)

English

The Effect of Sulphonylurea Therapy on Skeletal Muscle Glycogen Synthase Activity and Insulin Secretion in Newly Presenting Type 2 (Non-insulin-dependent) Diabetic Patients

scientific article published on April 1, 1991

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1828740

The Effect of Sulphonylurea Therapy on Skeletal Muscle Glycogen Synthase Activity and Insulin Secretion in Newly Presenting Type 2 (Non-insulin-dependent) Diabetic Patients (English)

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828740

4 December 2022

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

internal medicine

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

author name string

A. B. Johnson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828740

4 December 2022

M. Argyraki

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828740

4 December 2022

J. C. Thow

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828740

4 December 2022

I. R. Jones

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828740

4 December 2022

D. Broughton

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828740

4 December 2022

M. Miller

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828740

4 December 2022

R. Taylor

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828740

4 December 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1828740

4 December 2022

publication date

1 April 1991

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1828740

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-5491.1991.tb01580.x

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.1991.tb01580.x/fullpdf

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1828740

8

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1828740

3

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1828740

243-253

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1828740

Critical Variables in the Radioimmunoassay of Serum Insulin Using the Double Antibody Technic

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1991.TB01580.X

21 January 2018

Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1991.TB01580.X

21 January 2018

Comparison of plasma insulin levels following administration of tolbutamide and glucose

1

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Mechanism of improvement in glucose metabolism after chronic glyburide therapy

2

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non-insulin-dependent diabetic subjects.

4

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects.

5

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus

6

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes.

8

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization

9

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

10

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man

11

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Biosynthesis of glycogen from uridine diphosphate glucose

12

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism

13

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle

14

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Correlation between muscle glycogen synthase activity and in vivo insulin action in man.

15

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Impaired insulin-stimulated muscle glycogen synthase activation in vivo in man is related to low fasting glycogen synthase phosphatase activity

16

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography

17

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Muscle glycogen synthesis and disposition of infused glucose in humans with reduced rates of insulin-mediated carbohydrate storage.

18

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM.

19

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus

20

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus

21

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes

22

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Treatment of patients with non-insulin-dependent diabetes mellitus: diabetic control and insulin secretion and action after different treatment modalities

23

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

24

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Carbohydrate Oxidation and Storage in Obese Non-insulin-dependent Diabetic Patients: Effects of Improving Glycemic Control

25

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Influence of Continuous Physiologic Hyperinsulinemia on Glucose Kinetics and Counterregulatory Hormones in Normal and Diabetic Humans

26

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Impact of glucose ingestion on hepatic and peripheral glucose metabolism in man: an analysis based on simultaneous use of the forearm and double isotope techniques

27

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

An improved procedure for the assay of glycogen synthase and phosphorylase in rat liver homogenates

28

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Hexokinase type II from rat skeletal muscle

29

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Intravenous glucose tolerance and pancreatic islet beta-cell function in patients with multiple sclerosis during 2-yr treatment with cyclosporin

30

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Radioimmunological determination of human C-peptide in serum

32

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Blood glucose, lactate, pyruvate, glycerol, 3-hydroxybutyrate and acetoacetate measurements in man using a centrifugal analyser with a fluorimetric attachment

33

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Automated enzymatic determination of plasma free fatty acids by centrifugal analysis

34

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients.

35

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Modifications of glucose storage and oxidation in nonobese diabetics, measured by continuous indirect calorimetry

36

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Glyburide but not ciglitazone enhances insulin action in the liver independent of insulin receptor kinase activation

37

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Insulin Sensitivity and Insulin Binding to Monocytes in Maturity-Onset Diabetes

39

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Data on the distribution of fibre types in thirty-six human muscles. An autopsy study

41

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Relationships Between Fasting Plasma Glucose Levels and Insulin Secretion During Intravenous Glucose Tolerance Tests

44

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Paradoxical Inhibition of Insulin Secretion by Glucose in Human Diabetes Mellitus*

45

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy.

46

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

How does glibenclamide lower plasma glucose concentration in patients with type 2 diabetes?

47

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.

48

1 reference

10.1111/J.1464-5491.1991.TB01580.X

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01580.X

4 December 2022

Identifiers

10.1111/J.1464-5491.1991.TB01580.X

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1828740

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1828740

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51611436&oldid=1783984601"